Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,274.00
Bid: 2,282.00
Ask: 2,288.00
Change: -46.00 (-1.98%)
Spread: 6.00 (0.263%)
Open: 2,266.00
High: 2,312.00
Low: 2,258.00
Prev. Close: 2,320.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Bond Offering

17 May 2011 07:01

RNS Number : 7022G
Derwent London PLC
17 May 2011
 



17 May 2011

 

NOT FOR DISTRIBUTION IN OR TO THE U.S., CANADA, AUSTRALIA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW

 

Derwent London plc Convertible Bond Offering

 

Derwent London plc (the "Group", the "Company" or "Derwent London") today announces the launch of an offering of £175 million of Convertible Bonds due 2016 (the "Bonds") with an option to increase the offering to up to £200 million.

 

The Company intends to use the net proceeds of the offering to help fund its development pipeline and increase resources for future acquisition opportunities whilst also taking advantage of current favourable market conditions to diversify its medium-term sources of finance.

 

The Bonds are expected to be issued by Derwent London Capital (Jersey) Limited, a wholly-owned subsidiary of the Company incorporated in Jersey, and will be guaranteed by the Company. The Bonds will be senior and unsecured obligations of the Group and will be subject to a negative pledge.

 

The Bonds will be issued at par and are expected to carry a coupon of between 2.50% and 3.00% per annum payable semi-annually in arrear and will be convertible into fully paid Ordinary Shares of the Company (the "Shares") . The initial conversion price is expected to be set at a premium of between 25% and 30% above the volume weighted average price of the Shares from launch to pricing less £0.2025 to be paid to shareholders on the share register on 20 May 2011.

 

Settlement is expected to take place on or about 2 June 2011 (the "Settlement Date"). If not previously converted or redeemed, the Bonds will be redeemed at par on 15 July 2016. The Company will have the option to call all outstanding Bonds on or after the date falling 15 days after the Interest Payment Date falling in July 2014 at par plus accrued interest if the value of the Ordinary Shares underlying a Bond equals or exceeds 130% of the conversion price for at least 20 out of 30 consecutive dealing days or, at any time, if 15% or less of the principal amount of the Bonds remains outstanding.

 

It is intended that an application will be made for the Bonds to be listed on the Official List and admitted to trading on the Professional Securities Market of the London Stock Exchange.

 

J.P. Morgan Cazenove and RBS Hoare Govett Limited are acting as Joint Global Coordinators and Joint Bookrunners and HSBC Bank plc and UBS Limited are acting as Joint Bookrunners for the offering.

For further information, please contact:

Derwent London John Burns, Chief Executive Officer

Tel: +44 (0)20 7659 3000 Damian Wisniewski, Finance Director

 

About Derwent London plc

Derwent London plc is the largest central London focused REIT with an investment portfolio of £2.4bn as at 31 December 2010. The Group is one of London's most innovative office specialist property regenerators and investors and is well known for its established design-led philosophy and creative management approach to development.

 

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment, regeneration and redevelopment. The Group owns and manages an investment portfolio of 5.4 million sq ft (500,000m2), as at 31 December 2010, of which 95% is located in central London, with a specific focus on the West End and the areas bordering the City of London. Landmark schemes by Derwent London include Angel Building EC1, Arup Phases II & III W1, Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

 

Derwent London came first in the property sector in the 2010 awards for 'Britain's Most Admired Companies'.

 

DISCLAIMER

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities in the United States or in any other jurisdiction. This announcement is not for distribution, directly or indirectly in or into the United States (as defined in Regulation S under the US Securities Act of 1933, as amended (the "Securities Act")). The securities referred to herein have not been and will not be registered under the Securities Act and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

 

This communication is directed only at persons who (i) are outside the United Kingdom or (ii) have professional experience in matters relating to investments falling within Article 19(5) of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) are persons falling within Article 49 2(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). This communication must not be read, acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons.

 

The Joint Bookrunners are acting on behalf of the issuer and the Company and no one else in connection with the Bonds and will not be responsible to any other person for providing the protections afforded to clients of the Joint Bookrunners or for providing advice in relation to the Bonds.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Bookrunners or by any of their respective officers, employees or agents as to or in relation to the accuracy or completeness of this any written or oral information made available to any interested party or its advisers and any liability therefor is hereby expressly disclaimed.

Stabilisation/FSA.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODSFFEFMFFSESI
Date   Source Headline
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change
10th May 20241:00 pmRNSResults of 2024 Annual General Meeting
9th May 20247:00 amRNSFirst Quarter Business Update
7th May 20241:00 pmRNSAnnual Bondholders Meeting of LMS Limited
7th May 202410:00 amRNSAdditional Listing
1st May 202411:00 amRNSTotal Voting Rights
25th Apr 202410:00 amRNSSale of Turnmill EC1
9th Apr 20249:30 amRNSNotice of 2024 AGM and 2023 Report & Accounts
28th Mar 20244:45 pmRNSTotal Voting Rights
20th Mar 20245:13 pmRNSBlock listing Interim Review
12th Mar 202410:00 amRNSAdditional Listing
11th Mar 20244:45 pmRNSDirector/PDMR Shareholding
1st Mar 20243:00 pmRNSHolding(s) in Company
29th Feb 20244:45 pmRNSTotal Voting Rights
28th Feb 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
31st Jan 20244:45 pmRNSTotal Voting Rights
18th Jan 202411:00 amRNSNotice of Results
9th Jan 202410:10 amRNSHolding(s) in Company
29th Dec 20231:00 pmRNSTotal Voting Rights
1st Dec 20239:45 amRNSHolding(s) in Company
30th Nov 20234:45 pmRNSTotal Voting Rights
17th Nov 20235:35 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDerwent London plc Third Quarter Business Update
31st Oct 20234:45 pmRNSTotal Voting Rights
6th Oct 20239:30 amRNSHolding(s) in Company
5th Oct 20239:45 amRNSHolding(s) in Company
4th Oct 20239:47 amRNSHolding(s) in Company
21st Sep 20233:00 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSBlock listing Interim Review
19th Sep 202310:00 amRNSAdditional Listing
5th Sep 20239:30 amRNSHolding(s) in Company
31st Aug 20234:45 pmRNSTotal Voting Rights
10th Aug 20237:01 amRNSH2 2023 LETTING UPDATE
10th Aug 20237:00 amRNSDerwent London plc - UNAUDITED RESULTS
8th Aug 20233:00 pmRNSHolding(s) in Company
31st Jul 20234:45 pmRNSTotal Voting Rights
30th Jun 20234:45 pmRNSTotal Voting Rights
31st May 20234:45 pmRNSTotal Voting Rights
17th May 20235:30 pmRNSHolding(s) in Company
12th May 20233:00 pmRNSResult of AGM
10th May 20232:30 pmRNSBondholders Meeting
4th May 20237:00 amRNSQ1 2023 Business Update
28th Apr 20234:45 pmRNSTotal Voting Rights
13th Apr 20239:00 amRNS2022 Report & Accounts and Notice of AGM
4th Apr 20233:30 pmRNSDirector/PDMR Shareholding
31st Mar 20234:45 pmRNSTotal Voting Rights
21st Mar 20239:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.